212
Participants
Start Date
July 27, 2021
Primary Completion Date
July 25, 2023
Study Completion Date
August 14, 2023
BNC210
BNC210 900 mg twice daily (b.i.d.) for 12 weeks
Placebo
Placebo twice daily (b.i.d.) for 12 weeks
ATTUNE Study Clinical Trial Site, Staten Island
ATTUNE Study Clinical Trial Site, Cedarhurst
ATTUNE Study Clinical Trial Site, West Chester
ATTTUNE Study Clinical Trial Site, Jacksonville
ATTUNE Study Clinical Trial Site, Orlando
ATTUNE Study Clinical Trial Site, Miami Lakes
ATTUNE Study Clinical Trial Site, Lauderhill
ATTUNE Study Clinical Trial Site, Memphis
ATTUNE Study Clinical Trial Site, North Canton
ATTUNE Study Clinical Trial Site, Prairie Village
ATTUNE Study Clinical Trial Site, Overland Park
ATTUNE Study Clinical Trial Site, Oklahoma City
ATTUNE Study Clinical Trial Site, Dallas
ATTUNE Study Clinical Trial Site, Austin
ATTUNE Study Clinical Trial Site, Draper
ATTUNE Study Clinical Trial Site, Las Vegas
ATTUNE Study Clinical Trial Site, Beverly Hills
ATTUNE Study Clinical Trial Site, Bellflower
ATTUNE Study Clinical Trial Site, Oceanside
ATTUNE Study Clinical Trial Site, Colton
ATTUNE Study Clinical Trial Site, Temecula
ATTUNE Study Clinical Trial Site, Orange
ATTUNE Study Clinical Trial Site, New Bedford
ATTUNE Study Clinical Trial Site, Berlin
ATTUNE Study Clinical Trial Site, Cherry Hill
ATTUNE Study Clinical Trial Site, Barnsley
ATTUNE Study Clinical Trial Site, Blackpool
ATTUNE Study Clinical Trial Site, Cannock
ATTUNE Study Clinical Trial Site, Leeds
ATTUNE Study Clinical Trial Site, Liverpool
ATTUNE Study Clinical Trial Site, Manchester
ATTUNE Study Clinical Trial Site, Stockton-on-Tees
Lead Sponsor
Bionomics Limited
INDUSTRY